Briefs: Himadri Speciality Chemical and Rossari Biotech
General

Briefs: Himadri Speciality Chemical and Rossari Biotech

Rossari Biotech establishes new subsidiary in Singapore

  • By ICN Bureau | December 30, 2025

Himadri allots Rs. 200 crore commercial paper with 90-day tenure

Himadri Speciality Chemical Ltd has allotted commercial paper worth ₹200 crores on December 26, 2025, comprising 4,000 units of ₹5,00,000 each with a 90-day tenure and 6.20% interest rate. The unsecured instrument has been issued to Kotak Mahindra Bank with ICICI Bank Limited as the Issue and Paying Agent, scheduled to mature on March 26, 2026.

Rossari Biotech establishes new subsidiary in Singapore

Rossari Biotech has officially expanded its international footprint by incorporating a new subsidiary, Rossari (Singapore) Pte. Ltd. This strategic entry into the Singapore market is designed to serve as a regional hub, strengthening the company's presence and operational capabilities across Southeast Asia.

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization